| Segment Information |
18. Segment Information
The Company’s operations involve the development and usage, including licensing, of its proprietary DehydraTECH Technology. Lexaria is centrally managed and its chief operating decision makers, being the president and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property and Products. Licensing revenues are significantly concentrated on one licensee.
|
Three Months Ended
November 30, 2022
|
|
IP Licensing
$
|
|
|
B2B
$
|
|
|
Corporate
$
|
|
|
Consolidated Total
$
|
|
Revenue |
|
|
63,435 |
|
|
|
29,100 |
|
|
|
8,941 |
|
|
|
101,476 |
|
Cost of goods sold |
|
|
- |
|
|
|
(15,795 |
) |
|
|
- |
|
|
|
(15,795 |
) |
Operating expenses |
|
|
(707,034 |
) |
|
|
(10,992 |
) |
|
|
(1,136,961 |
) |
|
|
(1,854,987 |
) |
Segment income (loss) |
|
|
(643,599 |
) |
|
|
2,313 |
|
|
|
(1,128,020 |
) |
|
|
(1,769,306 |
) |
Total assets |
|
|
118,096 |
|
|
|
75,723 |
|
|
|
6,019,661 |
|
|
|
6,213,480 |
|
|
Three Months Ended
November 30, 2021
|
|
IP Licensing
$
|
|
|
Products
$
|
|
|
Corporate
$
|
|
|
Consolidated Total
$
|
|
External revenue |
|
|
- |
|
|
|
7,000 |
|
|
|
6,880 |
|
|
|
13,880 |
|
Cost of goods sold |
|
|
- |
|
|
|
(5,570 |
) |
|
|
- |
|
|
|
(5,570 |
) |
Operating expenses |
|
|
(837,750 |
) |
|
|
(77,002 |
) |
|
|
(1,097,040 |
) |
|
|
(2,011,792 |
) |
Segment loss |
|
|
(837,750 |
) |
|
|
(75,572 |
) |
|
|
(1,090,160 |
) |
|
|
(2,003,482 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
724,665 |
|
|
|
116,060 |
|
|
|
10,905,217 |
|
|
|
11,745,942 |
|
Capital Asset by Region |
|
Cost
US
|
|
|
Addition
US
|
|
|
Net Balance
US
|
|
|
Cost
Canada
|
|
|
Net Balance Canada |
|
|
Total Net Balance |
|
|
Three Months Ended
November 30, 2022
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Leasehold Improvements |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
259,981 |
|
|
|
51,786 |
|
|
|
51,786 |
|
Computers |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
70,781 |
|
|
|
8,174 |
|
|
|
8,174 |
|
Furniture & Fixtures |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
31,126 |
|
|
|
6,684 |
|
|
|
6,684 |
|
Lab Equipment |
|
|
140,487 |
|
|
|
20,500 |
|
|
|
116,553 |
|
|
|
193,185 |
|
|
|
128,024 |
|
|
|
244,577 |
|
|
|
|
140,487 |
|
|
|
20,500 |
|
|
|
116,553 |
|
|
|
555,073 |
|
|
|
194,668 |
|
|
|
311,221 |
|
Capital Asset by Region |
|
Cost
US
|
|
|
Addition
US
|
|
|
Net Balance
US
|
|
|
Cost
Canada
|
|
|
Addition Canada |
|
|
Net Balance Canada |
|
|
Total Net Balance |
|
Year Ended August 31, 2022 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Leasehold Improvements |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
259,981 |
|
|
|
- |
|
|
|
65,296 |
|
|
|
65,296 |
|
Computers |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
63,964 |
|
|
|
6,817 |
|
|
|
9,357 |
|
|
|
9,357 |
|
Furniture & Fixtures |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
31,126 |
|
|
|
- |
|
|
|
8,288 |
|
|
|
8,288 |
|
Lab Equipment |
|
|
98,050 |
|
|
|
42,375 |
|
|
|
100,031 |
|
|
|
193,185 |
|
|
|
- |
|
|
|
132,533 |
|
|
|
232,564 |
|
|
|
|
98,050 |
|
|
|
42,375 |
|
|
|
100,031 |
|
|
|
548,256 |
|
|
|
6,817 |
|
|
|
215,474 |
|
|
|
315,505 |
|
|